KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Non-Current Deferred Tax Liability (2018)

Historic Non-Current Deferred Tax Liability for NovoCure (NVCR) over the last 1 years, with Q4 2018 value amounting to $124000.0.

  • NovoCure's Non-Current Deferred Tax Liability changed N/A to $124000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $124000.0, marking a year-over-year change of. This contributed to the annual value of $124000.0 for FY2018, which is N/A changed from last year.
  • Per NovoCure's latest filing, its Non-Current Deferred Tax Liability stood at $124000.0 for Q4 2018.
  • Over the past 5 years, NovoCure's Non-Current Deferred Tax Liability peaked at $124000.0 during Q4 2018, and registered a low of $124000.0 during Q4 2018.